The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantation

Abstract

Pretransplant AT1R-Abs is an independent risk factor for AR, especially acute cellular rejection, and is possibly associated with the risk of antibody-mediated injury. Pretransplant assessment of AT1R-Abs may be useful for stratifying immunologic risks.